St. Jude Medical Announces US Launch And First Commercial Implants Of DRG Stimulation Therapy

St. Jude Medical, Inc., a global medical device company, recently announced the U.S. launch and first post-approval implants of the St. Jude Medical AxiumNeurostimulator System for dorsal root ganglion (DRG) stimulation to treat patients with chronic pain that has been hard to control with traditional spinal cord stimulation (SCS).
Source: Medical Design Online News - Category: Medical Equipment Source Type: news